Alora Patch Cost Without Insurance: 2026 Price, Status, and What to Switch To

Last verified: August 3, 2026 · Research and verification by The HRT Index · Editorial research — not medically reviewed by a clinician (our medical review policy)

Alora patch cost without insurance has no dependable current national price. FDA withdrew Alora’s approval on September 3, 2025 after AbbVie said it was no longer marketed; only lawful inventory already on hand could keep being dispensed until depleted or expired. Coupon pages do not prove stock. Replacement eight-patch references ran $35.82–$75 on August 3, 2026.

Sources: Federal Register, Drugs.com price guide, and HealthWarehouse.

This page is for you if

• Your pharmacy said Alora is discontinued, unavailable, or cannot be ordered.
• You have an Alora prescription and nobody has given you a clear next step.
• You found an Alora coupon online and want to know what the number actually represents.
• You are trying to price a currently marketed twice-weekly estradiol patch without insurance.

This page is not for you if

• You want general dosing guidance — see our estradiol patch dosage guide.
• Your current patch is backordered rather than withdrawn — see estradiol patch shortage alternatives.
• Your symptoms are mainly vaginal dryness or painful sex — that is a separate treatment decision covered in our guide to vaginal estrogen.

The question	The verified answer
Is there a dependable current brand Alora cash price?	No. Alora is no longer marketed, and its NDA approval was withdrawn.
Could any Alora inventory still be dispensed after withdrawal?	Yes, temporarily. FDA allowed lawful inventory already on hand on September 3, 2025 to be dispensed until depleted, expired, or otherwise unlawful.
Do current coupon pages prove that inventory exists?	No. They show database or coupon figures, not confirmed stock.
What do replacement-price references show?	$35.82–$53.05 for eight twice-weekly films in one public guide; one dispensing pharmacy listed an eight-pack at $75.
What should you do next?	Confirm the exact product, strength, quantity, stock, and prescription requirements with a pharmacist.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

Find My HRT Path → (about 90 seconds; no email needed)

---

What did we actually verify?

We would rather show you the evidence than ask you to trust a clean-looking price table.

The core price-and-status audit used nine sources: the Federal Register withdrawal notice, Alora’s FDA prescribing information, and seven public price or dispensing pages. We then checked FDA labeling updates, current DailyMed labels, ASHP shortage data, and provider pricing pages for the follow-up questions that could otherwise send you searching again.

Evidence level	What it means	What it covers on this page
Primary or authoritative source	We opened the government record, official drug label, or primary shortage bulletin itself.	Alora’s withdrawal, latest pre-withdrawal label, current replacement labels, FDA’s 2026 labeling changes, and ASHP’s product-level shortage report.
Public page verified August 3, 2026	We recorded the product, strength, quantity, price type, and page state that was visible.	GoodRx, SingleCare, SaveHealth, Hippo, WebMDRx, Drugs.com, and HealthWarehouse.
Company-stated	The company publishes the claim; we did not complete intake, purchase, or dispensing.	Sesame, Midi, Hers, and Winona pricing or program terms.
Not independently confirmed	The public page does not expose the fact needed to confirm it.	Local pharmacy stock, final coupon adjudication, the exact Winona patch manufacturer/NDC, and whether a specific Alora prescription can be substituted under state law.

What we did not do: We did not buy a patch, call a pharmacy, call AbbVie, complete a provider intake, or pose as a patient. A number that requires a live pharmacy transaction is treated as a public estimate, not a paid price.

---

How much does the Alora patch cost without insurance in 2026?

There is no reliable current national Alora cash price. Public pages still display Alora-related numbers, but they mix brand and generic products, one-patch and eight-patch quantities, retail references and coupon estimates. None of those pages proves that a licensed pharmacy has lawful, unexpired Alora inventory available to dispense.

The Ghost Price Ledger

Every commercial row below was checked on August 3, 2026. The selector state sits beside the price because a drug price without its product and quantity is not information. It is decoration.

Source	What the page was set to	Figure shown	What the figure actually proves
GoodRx	Alora, 0.025 mg/day, eight patches	$129.01	A public database cash figure for that configuration. It does not prove stock or a successful fill.
SingleCare	One box, eight twice-weekly patches, 0.1 mg/24 hr	$54.57 before a one-time $3 signup bonus	A coupon estimate for the selected configuration, not an adjudicated pharmacy price.
SingleCare	Retail answer labeled “8, packet (1 twice weekly patch), 0.025 mg/24 hr”	$137.69	A retail reference attached to internally confusing quantity language.
SaveHealth	Estradiol 0.05 mg/24 hr, one twice-weekly patch	$6.92–$22.08 across displayed pharmacies	A one-patch coupon estimate, not an eight-patch month.
Hippo	Alora brand, 0.025 mg/24 hr, one patch	$15.31–$34.37	Another one-patch estimate. It cannot be compared directly with an eight-patch box.
WebMDRx	Alora URL, but generic estradiol selected; 0.025 mg, one patch, ZIP 12850	No local coupon displayed	The brand page had defaulted to a generic one-patch search.
Drugs.com	Estradiol patch, twice-weekly, eight films	$35.82–$53.05, depending on strength	A pooled public price-guide reference across products; no manufacturer, NDC, pharmacy, or stock guarantee.
HealthWarehouse	Estradiol 0.075 mg/day, eight-patch pack, twice weekly	$75, listed in stock	A dispensing-pharmacy listing for a currently marketed generic configuration; fulfillment still depends on a valid prescription and live inventory.

Read the table carefully and the confusion resolves itself. GoodRx is showing eight patches. SaveHealth and Hippo are showing one. WebMDRx is on an Alora URL while searching generic estradiol. Drugs.com pools products without naming the manufacturer. HealthWarehouse is the only row above that pairs an eight-patch price with a pharmacy page showing stock.

That is the trap: the numbers look comparable because they all sit next to the word “patch.” They are not comparable.

Six kinds of price — and why mixing them ruins the answer

Price type	What it is	Who it binds
List or database price	A published reference figure from a pricing database	Nobody
Pharmacy cash quote	What one pharmacy says it will charge for the exact prescription	That pharmacy, at the time quoted
Coupon estimate	What a discount-card page predicts	Nobody until the card adjudicates
Adjudicated price	The amount produced when the pharmacy processes the card	The transaction at checkout
Program price	A price under a provider, manufacturer, or assistance program	Eligible participants under that program’s terms
Total first-fill cost	Visit, medication, shipping, and any required service fees	You, in real life

That last row is the one that matches your bank statement. It is also the one most price pages never calculate.

Your first move takes ten seconds: find the quantity beside the number. One patch, four, six, eight, or twenty-four? If the page does not say, the number is unusable.

---

Is the Alora patch discontinued or still available?

Alora is no longer marketed, and FDA withdrew approval of NDA 020655 effective September 3, 2025. The withdrawal covered all four Alora strengths. It was not a recall, and the notice does not identify a safety finding as the reason for withdrawal. (Federal Register)

The FDA record

The August 4, 2025 notice states that AbbVie and the other applicants told FDA their products were no longer marketed and requested withdrawal. The Alora row covers:

• 0.025 mg/24 hour
• 0.05 mg/24 hour
• 0.075 mg/24 hour
• 0.1 mg/24 hour

The sentence that settles the regulatory status is short: “Approval is withdrawn as of September 3, 2025.”

The residual-inventory rule changes the answer

The same notice allowed products already in inventory on September 3, 2025 to continue being dispensed until the inventory was depleted, expired, or otherwise became unlawful to dispense.

That means two things are true at once:

1. Alora is no longer marketed and has no active approved NDA.
2. The notice did not instantly make every unexpired package already in lawful inventory undispensable.

This is why “no pharmacy can legally dispense Alora” is too broad. The accurate answer is that there is no dependable current source we could verify, and a licensed pharmacy would need to confirm any claimed residual inventory, expiration date, and ability to dispense it.

Does withdrawn mean recalled?

No.

A recall removes or corrects distributed product because of a defect, risk, or legal problem. This notice withdrew approval after the applicants said the products were no longer marketed. It does not announce a recall, tell patients to stop using Alora, or identify a new safety defect.

If you still have unexpired Alora patches: ask your pharmacist or prescriber what to do. The notice itself contains no instruction to discard them, but it also gives you no renewable supply to plan around.

The verified timeline

Date	What happened	Source
May 2025	Latest Alora labeling revision reviewed	FDA prescribing information
July 30, 2025	Withdrawal notice signed	Federal Register
August 4, 2025	Notice published	Federal Register
September 3, 2025	Approval withdrawn	Federal Register
November 10, 2025	FDA requested menopause-hormone labeling changes from manufacturers	FDA
February 12, 2026	FDA announced the first six products with approved labeling changes	FDA

The Federal Register says the withdrawals were without prejudice to refiling. No current Alora relaunch or newly approved Alora application was identified in this verification.

---

Why do GoodRx and coupon sites still show Alora prices?

Legacy drug pages can remain visible after a product leaves the market, and commercial pages can mix brand, generic, strength, quantity, and price types. The useful question is not why a company’s database behaves that way. The useful question is whether the page identifies the exact product and whether a pharmacy can actually dispense it.

A price page is not proof of inventory

There are six steps between a number on a screen and a patch in your hand:

1. A price appears.
2. A coupon generates.
3. The pharmacy adjudicates the card.
4. The pharmacy can source the product.
5. The product is physically available and lawful to dispense.
6. The prescription is filled.

A price page proves step one. Sometimes it enables step two. It does not prove steps four through six.

SingleCare: the page conflicts with the FDA label

The SingleCare Alora page, marked updated August 3, 2026 when checked, repeatedly calls Alora’s active ingredient ethinyl estradiol. Alora’s FDA label identifies the active ingredient as estradiol. Those are not the same drug.

The page also says Alora contains a 1 mg patch. The FDA label instead lists total estradiol contents of 0.77, 1.5, 2.3, and 3.1 mg, corresponding to the four delivery strengths.

Then the price language shifts underneath the same number: the current coupon selector was 0.1 mg/24 hr, while FAQ answers attached $51.57 to 0.025 mg and 0.05 mg configurations. The regular displayed estimate was $54.57; $51.57 reflected a one-time $3 signup bonus.

This is not a reason to assume every SingleCare number is wrong. It is a reason to refuse a comparison until the product, strength, quantity, and bonus terms all match.

SaveHealth and Hippo: one patch is not one month

The SaveHealth Alora page displayed 0.05 mg/24 hr estradiol for one twice-weekly patch. Its quantity selector offered up to six patches, not the eight needed for a four-week twice-weekly comparison.

The Hippo Alora page likewise displayed a one-patch 0.025 mg configuration.

Do not multiply either one-patch figure by eight and call it a monthly price. Pharmacy pricing is not necessarily linear. SaveHealth itself showed one 0.05 mg patch at $9.37 at one pharmacy and six at $41 — $6.83 each, not $9.37 each.

WebMDRx: the brand URL had switched to generic

The WebMDRx Alora URL defaulted to generic estradiol, 0.025 mg, quantity one. It displayed no local coupon for the reference ZIP checked.

That is useful only as a warning: the page name in the browser is not enough. Read the selected drug and quantity inside the page.

GoodRx: an eight-patch figure still does not prove a fill

GoodRx displayed $129.01 for eight Alora 0.025 mg/day patches. That is the cleanest Alora-named quantity in the ledger, but it still does not establish stock, expiration, or a successful pharmacy transaction. The same result set attached “8 patches” and “3 cartons” to a 0.05 mg/day figure of $406.51, so we excluded that configuration from normalized comparisons rather than guessing which quantity controlled.

The three-field rule

Before comparing any two patch prices, confirm:

1. Brand or generic?
2. How many patches?
3. Once weekly or twice weekly?

If a listing will not tell you all three, it cannot answer your question.

---

What does a twice-weekly estradiol patch cost without insurance now?

A public price-guide snapshot checked August 3, 2026 listed eight twice-weekly estradiol films at $35.82–$53.05, depending on strength. Those are pooled reference prices rather than pharmacy guarantees. A dispensing pharmacy separately listed an eight-pack of 0.075 mg twice-weekly estradiol at $75 and marked it in stock.

Current public price guide by strength

Strength	Published guide price for eight twice-weekly films	Per patch	Approximate 13-fill year*
0.025 mg/24 hr	$35.83	$4.48	~$466
0.0375 mg/24 hr	$35.82	$4.48	~$466
0.05 mg/24 hr	$44.15	$5.52	~$574
0.075 mg/24 hr	$43.50	$5.44	~$566
0.1 mg/24 hr	$53.05	$6.63	~$690

*Eight patches changed twice weekly cover four weeks. About thirteen 28-day fills cover 52 weeks. Annual figures are arithmetic based on the published guide price and exclude visits, shipping, taxes, and future price changes. Source: Drugs.com estradiol patch price guide, checked August 3, 2026.

This is pooled data. Drugs.com does not identify a manufacturer, NDC, pharmacy, or therapeutic-equivalence grouping beside these figures, and its page warns that stock shortages and other variables prevent a guarantee.

The 13-fill trap quietly removes a month from your budget

Eight twice-weekly patches cover 28 days. Twelve 28-day fills cover 336 days — 29 days short of a 365-day year.

A full 52 weeks needs about 13 fills, not 12.

At $44.15 per fill, multiplying by 12 produces $529.80. Multiplying by 13 produces $573.95. That extra $44.15 is not a fee. It is the thirteenth four-week fill that calendar-month math erased.

A real dispensing-pharmacy listing can sit above the guide

On August 3, 2026, HealthWarehouse listed an eight-pack of 0.075 mg twice-weekly estradiol at $75, marked in stock and prescription required.

That does not make $75 a national price. It shows why a pooled guide and a fillable pharmacy listing can be different without either number being fraudulent.

Calculate your real 28-day cost

Use the exact quantity your pharmacy quotes:

• Eight patches, twice weekly: the quoted medication price is the four-week medication cost.
• Twenty-four patches, twice weekly: divide by three for a four-week comparison.
• One to six patches: do not extrapolate to eight unless the pharmacy confirms the eight-patch price.
• First fill: add any required clinical visit, medication, shipping, and service fees.
• Annual run rate: multiply a verified four-week recurring cost by about 13.

Cheapest fillable beats cheapest listed, every time.

Jump to the pharmacist script and price worksheet →

---

Is generic estradiol the same as Alora?

Alora contained estradiol, and FDA-approved estradiol transdermal systems remain available from other manufacturers. That does not mean any one of them can automatically be substituted on an Alora prescription. Therapeutic-equivalence ratings, strength, frequency, state substitution law, and the wording of the prescription all matter.

Why “it contains estradiol” does not settle substitution

A pharmacist needs to determine whether an available product is an approved therapeutic equivalent and whether substitution is allowed under state law and the prescription as written. If not, the prescriber needs to issue a new prescription.

A website can explain the variables. It cannot authorize the change.

Alora’s historical strength ladder

The latest Alora FDA label reviewed listed four delivery strengths and four physical patch sizes. It did not include 0.0375 mg/day. (FDA Alora prescribing information)

Alora delivery strength	Patch size	Total estradiol in the patch
0.025 mg/day	9 cm²	0.77 mg
0.05 mg/day	18 cm²	1.5 mg
0.075 mg/day	27 cm²	2.3 mg
0.1 mg/day	36 cm²	3.1 mg

Current twice-weekly labels for Dotti, Lyllana, and Vivelle-Dot include a 0.0375 mg/day strength.

That is a label difference to raise with the prescriber. It is not permission to choose or change a dose yourself.

The starting-dose labels differ

Alora’s historical label directed a 0.05 mg/day starting dose for vasomotor symptoms, vulvar and vaginal atrophy, and hypoestrogenism, and 0.025 mg/day for osteoporosis prevention.

The current Lyllana and Vivelle-Dot labels direct a 0.0375 mg/day starting dose for vasomotor symptoms. The fact that the labeled starting doses differ does not create a conversion formula between products. It tells you why the replacement product and strength must be written deliberately.

Two patches can have the same labeled delivery and look completely different

At 0.05 mg/day:

• Alora: 18 cm² and 1.5 mg total estradiol.
• Vivelle-Dot: 5.0 cm² and 0.78 mg total estradiol.

Alora was about 3.6 times the surface area and held about 1.9 times the total estradiol, despite the same labeled daily delivery.

Read that as a physical-design comparison only. Alora’s label warns against using exposure comparisons across estrogen products to infer efficacy or safety for an individual woman.

The adhesion data had limits

Alora’s label reports an adhesion study involving 408 women and 968 observations. About 97% of observations showed partial or complete adhesion, and about 3% were fully detached.

The part almost nobody repeats: the study used placebo patches in the 18 cm² size, participants were told not to bathe, swim, or exercise strenuously, and the 9, 27, and 36 cm² sizes were not studied for adhesion.

A lost patch is a real cost. It is also a product-use question for the pharmacist or prescriber, not a reason to improvise a replacement schedule.

Questions worth asking before accepting a different patch

• What is the exact product name?
• Who makes it?
• Is it once weekly or twice weekly?
• Is the strength the one my prescriber intended?
• What is the NDC?
• How many patches are in this fill?
• Can you substitute under state law and the prescription as written, or does my prescriber need to approve a change?

---

What changed about hormone patch warnings in 2026?

On February 12, 2026, FDA announced approved labeling changes for six menopausal hormone therapy products. The changes removed boxed-warning statements about cardiovascular disease, breast cancer, and probable dementia from those products, while retaining the endometrial-cancer warning for systemic estrogen-alone products. No twice-weekly estradiol patch appeared in that first public six-product list.

Alora’s label belongs to the pre-2026 labeling era

Alora’s latest FDA label reviewed was revised in May 2025. Its approval was withdrawn on September 3, 2025. FDA began the broader labeling request in November 2025 and announced the first approved changes in February 2026.

That means Alora’s old label should not be copied onto a replacement product as though it were the current label for that product.

Which products were in FDA’s first public update?

FDA listed:

• Bijuva
• Divigel
• Cenestin
• Enjuvia
• Prometrium
• Estring

Sources: FDA press announcement and FDA’s updated-product page.

The useful rule is simple: read the current prescribing information and patient leaflet for the product actually dispensed. Do not use Alora’s withdrawn May 2025 label as a substitute.

“Bioidentical” does not erase the FDA-approved versus compounded line

“Bioidentical” is not an FDA approval category. It is a descriptive and marketing term used in more than one context.

Alora was an FDA-approved estradiol product while its NDA was active. A generic estradiol transdermal system is also an FDA-approved drug if FDA approved that application.

A compounded hormone preparation is different. Compounded drugs are not FDA-approved, and FDA does not review them before marketing for safety, effectiveness, or quality. The Menopause Society states that custom-compounded hormone therapy has not been shown to be safer or more effective than approved products. (FDA compounding Q&A; The Menopause Society)

Those categories stay separate on this page. A compounded product is not presented as a generic Alora, an FDA-approved equivalent, or the default replacement for an FDA-approved patch.

---

Why is estradiol patch availability so uneven right now?

Supply problems in 2026 are product-specific: manufacturer, strength, and package size matter. ASHP’s July 1, 2026 shortage report listed some twice-weekly estradiol presentations as available and others as backordered, intermittently released, or allocated. Alora is different: it is no longer marketed and its approval was withdrawn.

A withdrawn brand is not a backorder. There is no ordinary restock date to wait for.

What ASHP reported on July 1, 2026

Manufacturer or product	ASHP status summarized from the affected presentations
Dotti (Amneal)	0.0375 and 0.1 mg/day listed available; 0.025, 0.05, and 0.075 mg/day listed on back order with no estimated release date.
Lyllana (Amneal)	0.025 and 0.0375 mg/day listed available; 0.05, 0.075, and 0.1 mg/day listed on back order with no estimated release date.
Viatris/Mylan twice-weekly estradiol	Listed presentations shown as available.
Noven	Certain presentations on intermittent back order, with product being released as available.
Zydus	Certain presentations on allocation.

Source: ASHP Drug Shortage Detail: Estradiol Transdermal System, updated July 1, 2026.

Shortage status is not “estradiol patches: yes or no.” It is a product-level answer that can change by strength.

Practical consequence: price and stock are separate questions. Ask both in the same call.

For the live replacement workflow, see estradiol patch shortage alternatives.

---

Is there an Alora coupon or savings card worth chasing?

Coupon pages still exist, but a coupon does not create inventory. No current manufacturer Alora savings-card path was verified in this audit. Even a valid discount would matter only if a licensed pharmacy confirmed lawful, unexpired residual inventory.

Here is the admission this page is built around:

We cannot give you a dependable way to buy Alora. Neither can a coupon page unless a licensed pharmacy confirms lawful, unexpired residual inventory.

And here is the turn:

The useful move is not chasing a database number. It is getting a prescription for a marketed product your pharmacy can actually source.

The four levers that matter are free:

1. Ask the residual-stock question once. Does the pharmacy have lawful, unexpired Alora inventory, yes or no?
2. Ask the substitution question. Can the pharmacist process an approved therapeutic equivalent under state law and the prescription as written, or is a new prescription required?
3. Match the comparison unit. Twice-weekly patches are commonly compared as eight-patch, four-week fills.
4. Name a marketed path. If substitution is not allowed, ask the prescriber to choose a currently marketed product and strength.

Those four questions do more than another hour of coupon hunting.

---

What should I ask my pharmacist and prescriber?

Ask the pharmacist to identify the exact product, strength, frequency, quantity, manufacturer or NDC, stock status, cash price, and adjudicated discount-card price. Then ask whether your Alora prescription can be processed for an approved therapeutic equivalent or whether the prescriber must issue a new prescription.

Copy the scripts. They are here rather than behind an email form because gating them would be obnoxious.

For your pharmacist

Ask this	Why it matters
“FDA withdrew Alora’s approval in September 2025. Do you have any lawful, unexpired Alora inventory, or is it unavailable?”	Resolves the residual-stock question without assuming the answer.
“Which twice-weekly estradiol transdermal systems do you have in stock at my strength?”	Stock is product- and strength-specific.
“Can you process my prescription with an approved therapeutic equivalent under state law and the way it was written, or do I need a new prescription?”	Tells you whether the next call goes to the prescriber.
“What is the cash price for eight patches before any discount card?”	Gives you a clean baseline.
“Can you run this card and tell me the adjudicated price?”	Converts an estimate into a transaction-specific answer.
“What is the manufacturer and NDC?”	Lets the prescriber and another pharmacy identify the exact product.

If you use a discount card, give the pharmacy every identifier printed on it — commonly BIN, PCN, group, and member ID. A screenshot of a headline price is not enough to adjudicate the card.

Write the answers down here

Field	Pharmacy answer
Product name
Brand or generic
Strength
Once weekly or twice weekly
Quantity
Manufacturer
NDC
Cash price
Adjudicated card price
In stock now
Can order
New prescription needed
Date and time checked

Fill this in at two pharmacies and you will know more about your real cost than a national coupon page can tell you.

For your prescriber’s office

Ask this	Why it matters
“Alora is no longer marketed. Which currently marketed product and strength do you want me to use?”	Gets the clinical decision into the prescription.
“Can the prescription permit substitution across approved equivalents when legally allowed?”	May reduce repeat calls when one manufacturer is unavailable.
“If twice-weekly patches remain unavailable at my strength, what backup route would you consider for me?”	Creates a second plan before the next stock problem.
“Does changing the product require a visit, or can your office handle it as a prescription change?”	Establishes the actual clinical-service cost instead of guessing.

---

Who can write the replacement prescription, and what does that cost?

If you already have a prescriber, start there. That clinician knows your history, and the office may be able to address the prescription without sending you through a new intake. If you do not have access to that prescriber, cash-pay telehealth is a later option — not a way to obtain Alora, but a way to be evaluated for a currently marketed treatment.

Affiliate disclosure: We may earn a commission if you use certain provider links. It does not change the price you pay or the verification standard applied here. See our full affiliate disclosure.

Route	Company-stated cost checked August 3, 2026	What the public price includes	The catch
Your existing prescriber	Practice-specific	Whatever the practice says it can handle without or with a visit	Do not assume the change is free; ask first.
Sesame	$59/month	Subscription care, video visits, unlimited messaging, and specified labs if ordered; medication is separate	State-specific lab-payment exceptions apply, Sesame does not bill insurance, and a prescription is never guaranteed.
Midi Health	$250 initial / $150 follow-up self-pay	Visit only; prescriptions and labs are separate	Commercial-insurance coverage varies. Midi says it cannot treat Medicaid or Medi-Cal patients, even self-pay; Medicare patients may self-pay but cannot submit claims.
Winona	Estrogen patch from $149/month	Company-stated clinician access, medication, and standard shipping	Winona calls the patch FDA-approved, but its public product page does not identify the exact manufacturer or NDC before intake. Cash-pay; no insurance billing.

Why Sesame’s $59/month is not an all-in patch price

Sesame’s official menopause page displayed $59/month when checked August 3, 2026. The page says medication cost is separate and that specified labs are included if the provider orders them, with payment exceptions in several states.

Do not add a public generic-patch guide price and present the result as a Sesame package. The subscription, prescribed product, pharmacy price, and any state-specific lab charge are separate facts.

Sesame’s published cancellation terms say you may self-cancel before the next billing cycle to avoid future charges; prior months are nonrefundable. Cancel at least three hours before the initial visit for a full refund. Once the initial visit occurs, the first month is nonrefundable.

Hers offers access to an estradiol pill or patch if prescribed, but its public menopause page did not display a comparable current patch price and says the service is not available in all 50 states. We excluded Hers from the cost ranking instead of guessing.

Why Winona is not the lowest-cost answer here — even though it pays us the most

At the time of this verification, Winona is our highest-paying affiliate partner. It is not the lowest-cost answer on this page.

Winona does not compete on medication-only cash price. If the lowest possible monthly drug cost is your priority, a local or mail-order generic is the better place to start. But Winona’s published $149/month patch program bundles clinician access, a company-stated FDA-approved patch if prescribed, medication, and standard shipping into one cash-pay path.

That can fit a woman who would rather pay more to stop making separate clinician and pharmacy calls. It is not the price winner for a woman who already has a prescriber and can fill an inexpensive generic.

The exact patch manufacturer and NDC are not public on the product page we checked, so the FDA-approved status is reported as company-stated until the dispensed product can be identified. Winona’s product page says refills are processed automatically and the subscription can be managed or canceled at any time; it does not state a refund rule on that product page.

Who should skip the telehealth comparison

• You already have a responsive prescriber: call that office first.
• You have insurance: check the prescriber and pharmacy path under your own plan before choosing cash-pay care.
• You have Medicaid or Medi-Cal: Midi is a hard no under its published policy; use your state-program network.
• You mainly need local vaginal treatment: read the vaginal estrogen guide before assuming a systemic patch is the right question.
• You are unsure whether online care fits your history: use Find My HRT Path, which also flags when an in-person starting point makes more sense.

See which provider model fits your situation → (about 90 seconds; no email needed)

---

What have women dealing with patch supply problems said?

We are not going to build a testimonial wall from anonymous posts or use personal stories as evidence that a medication is safe or effective.

The broader patch-supply problem is still emotionally relevant. AARP reported Dr. JoAnn Pinkerton of UVA Health describing the situation as “very frustrating and very inconvenient.” That report concerns the wider estradiol-patch shortage, not Alora’s separate withdrawal. (AARP)

That distinction matters. So does the feeling.

If you have been calling pharmacies, hearing three different answers, and wondering whether you are overreacting: you are not. The market data really is fragmented. The way out is to stop asking “Who has Alora?” as one giant question and break it into stock, substitution, product, quantity, and price.

---

What else should I know about Alora patch cost?

Can I still buy Alora anywhere?

We could not verify a dependable current source. FDA allowed lawful Alora inventory already on hand on September 3, 2025 to be dispensed until depleted, expired, or otherwise unlawful. A licensed pharmacy would need to confirm any claimed residual stock. A coupon page does not prove it exists.

Can I still fill an old Alora prescription?

Possibly only if a pharmacy has lawful, unexpired residual Alora inventory or can process the prescription for an approved therapeutic equivalent under state law and the prescription as written. Otherwise, the prescriber needs to issue a new prescription.

Is there a generic version of Alora?

FDA-approved generic estradiol transdermal systems exist. Whether a specific product is an approved therapeutic equivalent that the pharmacist may substitute for your Alora prescription depends on FDA’s Orange Book, state law, and the prescription wording. “Generic estradiol patch” and “automatically interchangeable with Alora” are not the same claim.

Was Alora recalled?

No. The August 2025 Federal Register notice withdrew approval after the applicants said the products were no longer marketed. It does not announce an Alora recall.

Was Alora withdrawn because it was unsafe?

The notice does not say that. It says the applicants reported that the products were no longer marketed and requested withdrawal. It identifies no new Alora safety finding as the reason.

How many Alora patches were a 28-day supply?

Eight. Alora’s historical label directed twice-weekly application, so eight patches covered four weeks. Follow the current prescription and label for the replacement product you actually receive.

What is the closest replacement to Alora?

The closest route-and-schedule category is a currently marketed twice-weekly estradiol transdermal system. FDA-labeled examples include Dotti, Lyllana, and Vivelle-Dot. The appropriate product and strength are clinical and dispensing decisions, not a website swap chart.

Will a replacement cost more or less?

It can cost less than the stale Alora figures. On August 3, 2026, one public guide listed eight twice-weekly estradiol films at about $35.82–$53.05, while a dispensing pharmacy listed an eight-pack at $75. Your actual price depends on product, strength, pharmacy, stock, and coupon adjudication.

Why is a one-patch coupon not one-eighth of a monthly price?

Because pharmacy pricing is not necessarily linear. On the SaveHealth page checked, one 0.05 mg patch was $9.37 at one pharmacy while six were $41, or $6.83 each. Multiplying a one-patch quote by eight can invent a number no pharmacy offered.

Does a cash patch price include a clinician visit?

Not unless the page says so. Keep the visit, medication, shipping, labs, follow-up, and service fees separate. Then add only the components your route actually requires.

Do I need a prescription for an estradiol patch?

Yes. Estradiol transdermal systems are prescription drugs. A clinician determines whether one is appropriate, and a licensed pharmacy dispenses it.

Can I switch patches myself?

No. The prescriber and pharmacist need to confirm the product, strength, frequency, therapeutic equivalence, and whether the prescription permits substitution.

Does Medicare cover Alora?

Alora is no longer marketed, so the useful question is whether your plan covers the replacement product. Check the exact product and NDC against your current formulary, then confirm the pharmacy price. Do not use a generic “Alora coverage” page as a current plan answer.

Is the cheapest coupon always the cheapest route?

No. A lower coupon estimate can lose to a lower pharmacy cash quote, an in-stock higher quote, or a 90-day fill. Ask for the cash price and the adjudicated card price for the same product and quantity.

Can I buy Alora from an overseas or unfamiliar online pharmacy?

Use a properly licensed pharmacy and verify the exact approved product. A site using the Alora name after the U.S. approval withdrawal is not proof that it is selling lawful, authentic, unexpired Alora.

Is there an Alora manufacturer savings card?

No current manufacturer Alora savings-card path was verified in this audit. More importantly, any card would be useless without confirmed lawful inventory.

---

How was this page produced?

Who: Research and verification by The HRT Index. This is editorial research and is not medically reviewed by a clinician. See our medical review policy.

How: We read the Federal Register withdrawal notice and Alora’s FDA prescribing information. We checked FDA’s 2026 labeling announcements, current DailyMed labels for replacement products, and ASHP’s product-level shortage report. We then recorded the product, strength, quantity, price type, and page state shown by seven public price or dispensing sources on August 3, 2026.

Why: A discontinued-brand price page is dangerous when it treats every number as a monthly, fillable price. This page exists to separate regulatory status, residual inventory, quantity, substitution, stock, and real cost so the reader can make one clean call instead of chasing seven incompatible numbers.

What remains personal to your transaction: local stock, expiration, prescription wording, state substitution law, final coupon adjudication, insurance coverage, and clinical appropriateness.

This page was built under The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded, verify state availability and insurance where the page uses them, and re-check on a fixed schedule. Provider research is evaluated on five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, access. We do not publish numeric provider scores.

Update schedule

Element	Refresh cadence	Verification method
Alora FDA status	Quarterly and event-driven	Federal Register, Drugs@FDA, and FDA labeling records
Coupon and cash-price pages	Monthly	Same product, strength, quantity, and reference ZIP; dated captures
Dispensing-pharmacy stock	Monthly	Live pharmacy page, then reader confirmation with the pharmacy
ASHP product-level shortage data	Weekly while active; monthly otherwise	ASHP shortage bulletin
Replacement labels	Quarterly and event-driven	DailyMed and FDA labeling records
Provider prices and program terms	Monthly	Official pricing, terms, and checkout pages
Internal links and tool timing	Each editorial update	Live-site check

Affiliate disclosure: Some provider links may generate a commission for The HRT Index. Payment never changes the facts reported, the order of the five verification pillars, or the recommendation. See the full affiliate disclosure.

---

Still not sure which HRT program is right for you?

Take our free matching quiz. In about 90 seconds, Find My HRT Path uses your state, insurance situation, medication-route preference, and key safety flags to show which provider model fits — or when online care is not the right starting point.

Find My HRT Path →

---

Educational content only. Not medical advice. Talk to a qualified clinician before starting, stopping, or changing any hormone therapy.